Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Thumbnail

Enzyme elimination method in mice improves healing after heart attack

A team of researchers at the University of Alabama at Birmingham (UAB) has found a way to improve healing and reduce inflammation after a heart attack using mouse models.

Thumbnail

Research links energy drinks to abnormal heart activity, high blood pressure

Because the number of hospital visits and deaths related to consuming energy drinks has increased in recent years, researchers looked at how they affect the heart and blood pressure—and the findings may make physicians think differently.

Mortality risk associated with infective endocarditis decreases in New York, California

From 1998 through 2013, the standardized incidence of infective endocarditis in New York and California remained stable between 7.6 and 7.8 cases per 100,000 persons each year, according to a retrospective database analysis. During that same period, the adjusted mortality risk related to infective endocarditis decreased 2 percent per year.

AATS provides updated guidelines for managing ischemic mitral regurgitation

The American Association for Thoracic Surgery (AATS) released updated evidence-based guidelines for managing ischemic mitral regurgitation.

Research finds azithromycin not linked to arrhythmias

Azithromycin, an antibiotic commonly used to treat bacterial infections has been associated with disrupting the heart’s normal rhythm, but a new study has debunked that theory, showing that the drug doesn’t cause ventricular arrhythmias.

Thumbnail

Multidisciplinary, team approach benefits TAVR patients

A recent survey from the Society of Thoracic Surgeons (STS) found that 77.5 percent of cardiac surgeons were involved in TAVR procedures as part of multidisciplinary heart teams.

Researchers clarify how zinc levels effect cardiac function

A new study by researchers at the Technical University of Munich in Germany clarifies the relationship between levels of zinc and its effect on cardiac function.

Thumbnail

Researchers find simpler way to link atherosclerosis to heart disease

New research from the New York Institute of Technology College of Osteopathic Medicine (NYITCOM) has found that by examining the health of peripheral arteries, providers could better predict the risk of patients developing ischemic cardiovascular disease.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.